...
azn-img

AstraZeneca PLC ADR, Common Stock

AZN

NSQ

$66.3

-$0.33

(-0.5%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$206.59B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
32.1884
Volume info-icon
This is the total number of shares traded during the most recent trading day.
0
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
2.27%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.18
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$59.19 L
$87.67 H
$66.3

About AstraZeneca PLC ADR, Common Stock

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameAZNSectorS&P500
1-Week Return-0.82%-0.33%-1.49%
1-Month Return0.35%-4.57%-0.37%
3-Month Return-13.32%-9.96%3.89%
6-Month Return-16.05%-5.67%9.34%
1-Year Return0.2%2.53%25.19%
3-Year Return14.76%-1.43%24.7%
5-Year Return33.61%34.73%85.39%
10-Year Return89.18%102.14%187.19%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue24.38B26.62B37.42B44.35B45.81B[{"date":"2019-12-31","value":53.23,"profit":true},{"date":"2020-12-31","value":58.1,"profit":true},{"date":"2021-12-31","value":81.68,"profit":true},{"date":"2022-12-31","value":96.81,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue4.92B5.30B12.44B12.39B8.04B[{"date":"2019-12-31","value":39.57,"profit":true},{"date":"2020-12-31","value":42.61,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.63,"profit":true},{"date":"2023-12-31","value":64.65,"profit":true}]
Gross Profit19.46B21.32B24.98B31.96B37.77B[{"date":"2019-12-31","value":51.53,"profit":true},{"date":"2020-12-31","value":56.44,"profit":true},{"date":"2021-12-31","value":66.14,"profit":true},{"date":"2022-12-31","value":84.62,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin79.82%80.09%66.76%72.06%82.45%[{"date":"2019-12-31","value":96.81,"profit":true},{"date":"2020-12-31","value":97.14,"profit":true},{"date":"2021-12-31","value":80.97,"profit":true},{"date":"2022-12-31","value":87.4,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses16.27B16.16B23.92B28.20B29.58B[{"date":"2019-12-31","value":54.99,"profit":true},{"date":"2020-12-31","value":54.62,"profit":true},{"date":"2021-12-31","value":80.88,"profit":true},{"date":"2022-12-31","value":95.35,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income2.92B5.16B1.06B3.76B8.19B[{"date":"2019-12-31","value":35.69,"profit":true},{"date":"2020-12-31","value":63.01,"profit":true},{"date":"2021-12-31","value":12.89,"profit":true},{"date":"2022-12-31","value":45.86,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(2.61B)(2.46B)(2.58B)(2.51B)(2.58B)[{"date":"2019-12-31","value":-261300000000,"profit":false},{"date":"2020-12-31","value":-246500000000,"profit":false},{"date":"2021-12-31","value":-257800000000,"profit":false},{"date":"2022-12-31","value":-250700000000,"profit":false},{"date":"2023-12-31","value":-258200000000,"profit":false}]
Pre-Tax Income1.55B3.92B(265.00M)2.50B6.90B[{"date":"2019-12-31","value":22.44,"profit":true},{"date":"2020-12-31","value":56.76,"profit":true},{"date":"2021-12-31","value":-3.84,"profit":false},{"date":"2022-12-31","value":36.25,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income Taxes321.00M772.00M(380.00M)(792.00M)938.00M[{"date":"2019-12-31","value":34.22,"profit":true},{"date":"2020-12-31","value":82.3,"profit":true},{"date":"2021-12-31","value":-40.51,"profit":false},{"date":"2022-12-31","value":-84.43,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes1.23B3.14B115.00M3.29B5.96B[{"date":"2019-12-31","value":20.58,"profit":true},{"date":"2020-12-31","value":52.74,"profit":true},{"date":"2021-12-31","value":1.93,"profit":true},{"date":"2022-12-31","value":55.24,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income From Continuous Operations1.23B3.14B115.00M3.29B5.96B[{"date":"2019-12-31","value":20.58,"profit":true},{"date":"2020-12-31","value":52.74,"profit":true},{"date":"2021-12-31","value":1.93,"profit":true},{"date":"2022-12-31","value":55.24,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income1.33B3.20B112.00M3.29B5.96B[{"date":"2019-12-31","value":22.42,"profit":true},{"date":"2020-12-31","value":53.67,"profit":true},{"date":"2021-12-31","value":1.88,"profit":true},{"date":"2022-12-31","value":55.21,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
EPS (Diluted)1.772.022.653.343.64[{"date":"2019-12-31","value":48.63,"profit":true},{"date":"2020-12-31","value":55.49,"profit":true},{"date":"2021-12-31","value":72.8,"profit":true},{"date":"2022-12-31","value":91.76,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

AZN
Cash Ratio 0.19
Current Ratio 0.93
Quick Ratio 0.71

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

AZN
ROA (LTM) 8.50%
ROE (LTM) 16.66%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

AZN
Debt Ratio Lower is generally better. Negative is bad. 0.61
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.39

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

AZN
Trailing PE 32.19
Forward PE 14.24
P/S (TTM) 4.03
P/B 5.07
Price/FCF 102
EV/R 4.49
EV/Ebitda 15.45
PEG 0.71

FAQs

What is AstraZeneca PLC ADR share price today?

AstraZeneca PLC ADR (AZN) share price today is $66.3

Can Indians buy AstraZeneca PLC ADR shares?

Yes, Indians can buy shares of AstraZeneca PLC ADR (AZN) on Vested. To buy AstraZeneca PLC ADR from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AZN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of AstraZeneca PLC ADR be purchased?

Yes, you can purchase fractional shares of AstraZeneca PLC ADR (AZN) via the Vested app. You can start investing in AstraZeneca PLC ADR (AZN) with a minimum investment of $1.

How to invest in AstraZeneca PLC ADR shares from India?

You can invest in shares of AstraZeneca PLC ADR (AZN) via Vested in three simple steps:

  • Click on Sign Up or Invest in AZN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in AstraZeneca PLC ADR shares
What is AstraZeneca PLC ADR 52-week high and low stock price?

The 52-week high price of AstraZeneca PLC ADR (AZN) is $87.67. The 52-week low price of AstraZeneca PLC ADR (AZN) is $59.19.

What is AstraZeneca PLC ADR price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of AstraZeneca PLC ADR (AZN) is 32.1884

What is AstraZeneca PLC ADR price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of AstraZeneca PLC ADR (AZN) is 5.07

What is AstraZeneca PLC ADR dividend yield?

The dividend yield of AstraZeneca PLC ADR (AZN) is 2.27%

What is the Market Cap of AstraZeneca PLC ADR?

The market capitalization of AstraZeneca PLC ADR (AZN) is $206.59B

What is AstraZeneca PLC ADR’s stock symbol?

The stock symbol (or ticker) of AstraZeneca PLC ADR is AZN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top